Weekly Insulin Injection Approved for Sale in Israel
Translated & summarized from Israel Hayom by baba
A new once-weekly insulin injection, Awiqli, is now available for private purchase in Israel, offering an alternative to daily shots for diabetes patients. The U.S. FDA approved it for adults and recently for children aged 10 and up with type 2 diabetes. Prices in Israel range from 280 to 527 shekels per package, which can last up to 12 weeks, but it is not yet covered by the national health basket.
The story in 5 lines · by baba
- Novo Nordisk's once-weekly insulin, Awiqli, is now sold privately in Israel.
- The U.S. FDA approved Awiqli for adults and recently for children aged 10+ with type 2 diabetes.
- Awiqli offers an alternative to daily insulin injections for diabetes management.
- Prices in Israel range from 280 to 527 shekels per package, lasting up to 12 weeks.
- The new insulin is not currently included in Israel's national health basket.
A new once-weekly insulin injection, Awiqli (icodec insulin) by Novo Nordisk, is now available for purchase in Israel, offering an alternative to daily injections for many diabetes patients. The U.S. Food and Drug Administration (FDA) had previously approved Awiqli for adults earlier in the year and expanded its approval in late October to include children and adolescents aged 10 and older with type 2 diabetes. This marks the first weekly insulin approved in the U.S. for pediatric use, based on a small study of 18 children and mathematical modeling, rather than a large efficacy trial. The study indicated faster absorption in children with the first dose, with levels normalizing after subsequent doses to match those in adults, leading the FDA to estimate similar blood sugar control effects. This development is significant as type 2 diabetes, once considered an adult disease, is increasingly diagnosed in obese children.
Common side effects associated with Awiqli are similar to other insulins, including low blood sugar, injection site reactions, rash, itching, swelling, and weight gain. In Israel, the drug will initially be sold privately, with prices ranging from 280 to 527 shekels per package, depending on dosage. A single package can last up to 12 weeks. The medication is not currently included in the national health basket.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Right 1Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
